Online Database of Chemicals from Around the World
(2Z)-4-[(1R,3aS,5S,6S,6aR,11S,14aS)-3a,4,5,6,6a,7-Hexahydro-6,8-dihydroxy-3,3,11-trimethyl-13-(3-methyl-2-buten-1-yl)-11-(4-methyl-3-penten-1-yl)-7,15-dioxo-1,5-methano-1H,3H,11H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-2-methyl-2-butenoic acid
[CAS# 1097882-33-1]
Complete supplier list of (2Z)-4-[(1R,3aS,5S,6S,6aR,11S,14aS)-3a,4,5,6,6a,7-Hexahydro-6,8-dihydroxy-3,3,11-trimethyl-13-(3-methyl-2-buten-1-yl)-11-(4-methyl-3-penten-1-yl)-7,15-dioxo-1,5-methano-1H,3H,11H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-2-methyl-2-butenoic acid
|
Identification
Name |
(2Z)-4-[(1R,3aS,5S,6S,6aR,11S,14aS)-3a,4,5,6,6a,7-Hexahydro-6,8-dihydroxy-3,3,11-trimethyl-13-(3-methyl-2-buten-1-yl)-11-(4-methyl-3-penten-1-yl)-7,15-dioxo-1,5-methano-1H,3H,11H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-2-methyl-2-butenoic acid |
|
Molecular Structure |
![CAS # 1097882-33-1, (2Z)-4-[(1R,3aS,5S,6S,6aR,11S,14aS)-3a,4,5,6,6a,7-Hexahydro-6,8-dihydroxy-3,3,11-trimethyl-13-(3-methyl-2-buten-1-yl)-11-(4-methyl-3-penten-1-yl)-7,15-dioxo-1,5-methano-1H,3H,11H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-2-methyl-2-butenoic acid](/structures/1097882-33-1.gif) |
Molecular Formula |
C38H46O9 |
Molecular Weight |
646.77 |
CAS Registry Number |
1097882-33-1 |
|
Properties
Solubility |
Insoluble (1.9E-5 g/L) (25 ºC), Calc.* |
Density |
1.31±0.1 g/cm3 (20 ºC 760 Torr), Calc.* |
|
*
|
Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2016 ACD/Labs)
|
|
Market Analysis Reports |
List of Reports Available for (2Z)-4-[(1R,3aS,5S,6S,6aR,11S,14aS)-3a,4,5,6,6a,7-Hexahydro-6,8-dihydroxy-3,3,11-trimethyl-13-(3-methyl-2-buten-1-yl)-11-(4-methyl-3-penten-1-yl)-7,15-dioxo-1,5-methano-1H,3H,11H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-2-methyl-2-butenoic acid
|
|
Related Products
Hexahydro-1H-1,4-diazepine-1-acetic acid ethyl ester Hexahydro-1H-1,4-diazepine-1-carboxylic acid tert-butyl ester hydrochloride Hexahydro-1H-1,4-diazepine-2-methanol Hexahydro-1H-1,4-diazepine-5-methanol Hexahydro-1H-1,4-diazepine-6-methanol Hexahydro-2H-1,4-diazepin-2-one Hexahydro-2H-1,4-diazepin-2-one hydrochloride (1:1) 1-(Hexahydro-1H-1,4-diazepin-1-yl)-3,3-dimethyl-1-butanone 1,5a,6,9,9a,9b-Hexahydro-4a(4H)-dibenzofurancarboxaldehyde (3S,11E)-3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-(methyl-13C)-1H-2-benzoxacyclotetradecin-1,7(8H)-dione-13C17 [2R-(2a,3b,11bb)]-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol 1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one (5aR,6aR,7aS)-Hexahydro-3,3-dimethyl-3H,5H-cycloprop[d]oxazolo[3,4-a]pyridin-5-one 1,2,5,6,7,8-Hexahydro-7,7-dimethyl-2-oxo-3-quinolinecarboxylic acid Hexahydro-2'3a-dimethylspiro[1,3-dithiolo[4,5-b]furan-2,3'(2'H)-furan] (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl 2,2-dimethyl-3-butenoate 6,7,8,9,10,10a-Hexahydro-N,N-dimethyl-2-(trifluoromethyl)benzo[b]cyclohepta[e][1,4]thiazine-11(5aH)-propanamine monohydrochloride dihydrate 2,3,6a,7,8,9-Hexahydro-11H-1,4-dioxino[2,3-g]pyrrolo[2,1-b][1,3]benzoxazin-11-one 4-(1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl)-N-8-quinolinylbenzamide rel-4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide